# Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

> **NCT01399450** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 11 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** paliperidone

## Key facts

- **NCT ID:** NCT01399450
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399450, "Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01399450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*